Verenium

About:

Verenium is an industrial biotechnology company specializing in the development of high performance enzymes.

Website: http://www.verenium.com

Twitter/X: verenium

Top Investors: BP, Athyrium Capital Management LP

Description:

Verenium possesses integrated, end-to-end capabilities in pre-treatment, novel enzyme development, fermentation, engineering, and project development and is moving rapidly to commercialize its proprietary technology for the production of cellulosic ethanol from a wide array of feedstocks, including sugarcane bagasse, dedicated energy crops, agricultural waste, and wood products. In addition to the vast potential for advanced biofuels, a multitude of large-scale industrial opportunities exist for the Company for products derived from the production of low-cost, biomass-derived sugars.

Total Funding Amount:

$113M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Cambridge, Maine, United States

Founded Date:

1992-01-01

Contact Email:

ir(AT)verenium.com

Founders:

Craig Venter

Number of Employees:

10001+

Last Funding Date:

2012-12-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai